Literature DB >> 26562699

Relationship of Estimated SHIV Acquisition Time Points During the Menstrual Cycle and Thinning of Vaginal Epithelial Layers in Pigtail Macaques.

Ellen N Kersh1, Jana Ritter, Katherine Butler, Sharon Dietz Ostergaard, Debra Hanson, Shanon Ellis, Sherif Zaki, Janet M McNicholl.   

Abstract

BACKGROUND: HIV acquisition in the female genital tract remains incompletely understood. Quantitative data on biological HIV risk factors, the influence of reproductive hormones, and infection risk are lacking. We evaluated vaginal epithelial thickness during the menstrual cycle in pigtail macaques (Macaca nemestrina). This model previously revealed increased susceptibility to vaginal infection during and after progesterone-dominated periods in the menstrual cycle.
METHODS: Nucleated and nonnucleated (superficial) epithelial layers were quantitated throughout the menstrual cycle of 16 macaques. We examined the relationship with previously estimated vaginal SHIVSF162P3 acquisition time points in the cycle of 43 different animals repeatedly exposed to low virus doses.
RESULTS: In the luteal phase (days 17 to cycle end), the mean vaginal epithelium thinned to 66% of mean follicular thickness (days 1-16; P = 0.007, Mann-Whitney test). Analyzing 4-day segments, the epithelium was thickest on days 9 to 12 and thinned to 31% thereof on days 29 to 32, with reductions of nucleated and nonnucleated layers to 36% and 15% of their previous thickness, respectively. The proportion of animals with estimated SHIV acquisition in each cycle segment correlated with nonnucleated layer thinning (Pearson r = 0.7, P < 0.05, linear regression analysis), but not nucleated layer thinning (Pearson r = 0.6, P = 0.15).
CONCLUSIONS: These data provide a detailed picture of dynamic cycle-related changes in the vaginal epithelium of pigtail macaques. Substantial thinning occurred in the superficial, nonnucleated layer, which maintains the vaginal microbiome. The findings support vaginal tissue architecture as susceptibility factor for infection and contribute to our understanding of innate resistance to SHIV infection.

Entities:  

Mesh:

Year:  2015        PMID: 26562699      PMCID: PMC4646715          DOI: 10.1097/OLQ.0000000000000367

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  30 in total

1.  Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells.

Authors:  Caroline M Mitchell; Leslie McLemore; Katharine Westerberg; Rena Astronomo; Kimberly Smythe; Carolyn Gardella; Matthias Mack; Amalia Magaret; Dorothy Patton; Kathy Agnew; M Juliana McElrath; Florian Hladik; David Eschenbach
Journal:  J Infect Dis       Date:  2014-03-20       Impact factor: 5.226

2.  The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.

Authors:  C K Mauck; M M Callahan; J Baker; K Arbogast; R Veazey; R Stock; Z Pan; C S Morrison; M Chen-Mok; D F Archer; H L Gabelnick
Journal:  Contraception       Date:  1999-07       Impact factor: 3.375

3.  Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.

Authors:  M Valeria Bahamondes; Sara Castro; Nadia M Marchi; Michele Marcovici; Liliana A L A Andrade; Arlete Fernandes; Luis Bahamondes
Journal:  Contraception       Date:  2014-02-07       Impact factor: 3.375

4.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition.

Authors:  H L Martin; B A Richardson; P M Nyange; L Lavreys; S L Hillier; B Chohan; K Mandaliya; J O Ndinya-Achola; J Bwayo; J Kreiss
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

5.  A combined oral contraceptive affects mucosal SHIV susceptibility factors in a pigtail macaque (Macaca nemestrina) model.

Authors:  Sharon Dietz Ostergaard; Katherine Butler; Jana M Ritter; Ryan Johnson; Jeanine Sanders; Nathaniel Powell; George Lathrop; Sherif R Zaki; Janet M McNicholl; Ellen N Kersh
Journal:  J Med Primatol       Date:  2014-12-23       Impact factor: 0.667

6.  SHIV susceptibility changes during the menstrual cycle of pigtail macaques.

Authors:  Ellen N Kersh; Tara Henning; Sundaram A Vishwanathan; Monica Morris; Katherine Butler; Debra R Adams; Patricia Guenthner; Priya Srinivasan; James Smith; Jessica Radzio; J Gerardo Garcia-Lerma; Charles Dobard; Walid Heneine; Janet McNicholl
Journal:  J Med Primatol       Date:  2014-04-29       Impact factor: 0.667

Review 7.  Estimating per-act HIV transmission risk: a systematic review.

Authors:  Pragna Patel; Craig B Borkowf; John T Brooks; Arielle Lasry; Amy Lansky; Jonathan Mermin
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

Review 8.  Research gaps in defining the biological link between HIV risk and hormonal contraception.

Authors:  Kerry Murphy; Susan C Irvin; Betsy C Herold
Journal:  Am J Reprod Immunol       Date:  2014-02-19       Impact factor: 3.886

9.  Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques.

Authors:  Katherine Butler; Jana Ritter; Shanon Ellis; Tara R Henning; Jeltley Montague; Sherif Zaki; David Garber; Janet M McNicholl; Ellen N Kersh
Journal:  J Med Primatol       Date:  2015-08-04       Impact factor: 0.667

10.  Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.

Authors:  Charles S Morrison; Pai-Lien Chen; Cynthia Kwok; Jared M Baeten; Joelle Brown; Angela M Crook; Lut Van Damme; Sinead Delany-Moretlwe; Suzanna C Francis; Barbara A Friedland; Richard J Hayes; Renee Heffron; Saidi Kapiga; Quarraisha Abdool Karim; Stephanie Karpoff; Rupert Kaul; R Scott McClelland; Sheena McCormack; Nuala McGrath; Landon Myer; Helen Rees; Ariane van der Straten; Deborah Watson-Jones; Janneke H H M van de Wijgert; Randy Stalter; Nicola Low
Journal:  PLoS Med       Date:  2015-01-22       Impact factor: 11.069

View more
  7 in total

1.  The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.

Authors:  Brenna L Hughes; Riana Dutt; Christina Raker; Melody Barthelemy; Richard M Rossoll; Bharat Ramratnam; Charles R Wira; Susan Cu-Uvin
Journal:  Am J Obstet Gynecol       Date:  2016-07-05       Impact factor: 8.661

Review 2.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

Review 3.  Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.

Authors:  Gregory Q Del Prete; Jeffrey D Lifson; Brandon F Keele
Journal:  Curr Opin HIV AIDS       Date:  2016-11       Impact factor: 4.283

4.  Evaluation of the Pig-Tailed Macaque (Macaca nemestrina) as a Model of Human Staphylococcus aureus Nasal Carriage.

Authors:  Amy L Cole; Yvonne Cosgrove Sweeney; Amanda G Lasseter; Justin M Gray; Ashley C Beavis; Christine F Chong; Safarali V Hajheidari; Alex Beyene; Dorothy L Patton; Alexander M Cole
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

5.  Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice.

Authors:  Jocelyn M Wessels; Philip V Nguyen; Danielle Vitali; Kristen Mueller; Fatemeh Vahedi; Allison M Felker; Haley A Dupont; Puja Bagri; Chris P Verschoor; Alexandre Deshiere; Tony Mazzulli; Michel J Tremblay; Ali A Ashkar; Charu Kaushic
Journal:  Sci Rep       Date:  2021-02-16       Impact factor: 4.379

6.  Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract.

Authors:  Ann M Carias; Shannon A Allen; Angela J Fought; Katarina Kotnik Halavaty; Meegan R Anderson; Maria L Jimenez; Michael D McRaven; Casey J Gioia; Tara R Henning; Ellen N Kersh; James M Smith; Lara E Pereira; Katherine Butler; S Janet M McNicholl; R Michael Hendry; Patrick F Kiser; Ronald S Veazey; Thomas J Hope
Journal:  PLoS Pathog       Date:  2016-09-22       Impact factor: 6.823

7.  Characterization of the Genital Mucosa Immune Profile to Distinguish Phases of the Menstrual Cycle: Implications for HIV Susceptibility.

Authors:  Geneviève Boily-Larouche; Julie Lajoie; Brenden Dufault; Kenneth Omollo; Juliana Cheruiyot; Jane Njoki; Monika Kowatsch; Makobu Kimani; Joshua Kimani; Julius Oyugi; Keith R Fowke
Journal:  J Infect Dis       Date:  2019-02-23       Impact factor: 5.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.